Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2024

09-02-2024 | Septicemia | Original Article

Restoration of the Mucosal IgA Response by Improving CD4+ T Pyroptosis Fails to Attenuate Gut Bacterial Translocation and Organ Damage After LPS Attack

Authors: Zi-Meng Liu, Yi-nan Zhang, Hu-fei Zhang, Xiao-jun Chen, Hui Peng, Xu-Yu Zhang

Published in: Digestive Diseases and Sciences | Issue 3/2024

Login to get access

Abstract

Background

Currently, the mechanisms of impaired gut mucosal immunity in sepsis remain unclear. Gut immunoglobulin A (IgA) is an important defense mechanism against invasive pathogens, and CD4+ T cells regulate the IgA response.

Aim

We aimed to verify the hypothesis indicating that CD4+ T pyroptosis induced by lipopolysaccharide (LPS) leads to an impaired gut IgA response and subsequent bacterial translocation and organ damage.

Methods

Cultured CD4+ T cells and mice were manipulated with LPS, and pyroptosis was improved by A438079 or adoptive CD4+ T cell transfer. The changes demonstrated in pyroptosis-related molecules, cytotoxicity and CD4+ T cells were examined to determine CD4+ T pyroptosis. The changes demonstrated in IgA+ B cells, AID (key enzyme for immunoglobulins) and IgA production and function were examined to evaluate the IgA response. Serum biomarkers, bacterial colonies and survival analysis were detected for bacterial translocation and organ damage.

Results

LPS attack induced CD4+ T pyroptosis, as evidenced by increased expression of P2X7, Caspase-11 and cleaved GSDMD, which elevated cytotoxicity and decreased CD4+ T cells. Decreased CD4+ T subsets (Foxp3+ T and Tfh cells) influenced the IgA response, as evidenced by lower AID expression, which decreased IgA+ B cells and IgA production and function. A438079 or cell transfer improved the IgA response but failed to reduce the translocation of gut pathogens, damage to the liver and kidney, and mortality of mice.

Conclusion

LPS attack results in CD4+ T pyroptosis. Improvement of pyroptosis restores the mucosal IgA response but fails to ameliorate bacterial translocation and organ damage.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mira JC, Gentile LF, Mathias BJ et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med. 2017;45:253–262.CrossRefPubMedPubMedCentral Mira JC, Gentile LF, Mathias BJ et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med. 2017;45:253–262.CrossRefPubMedPubMedCentral
2.
go back to reference Amornphimoltham P, Yuen PST, Star RA, Leelahavanichkul A. Gut leakage of fungal-derived inflammatory mediators: part of a gut-liver-kidney axis in bacterial sepsis. Dig Dis Sci. 2019;64:2416–2428.CrossRefPubMed Amornphimoltham P, Yuen PST, Star RA, Leelahavanichkul A. Gut leakage of fungal-derived inflammatory mediators: part of a gut-liver-kidney axis in bacterial sepsis. Dig Dis Sci. 2019;64:2416–2428.CrossRefPubMed
3.
go back to reference Longhitano Y, Zanza C, Thangathurai D et al. Gut alterations in septic patients: a biochemical literature review. Rev Recent Clin Trials 2020;15:289–297.CrossRefPubMed Longhitano Y, Zanza C, Thangathurai D et al. Gut alterations in septic patients: a biochemical literature review. Rev Recent Clin Trials 2020;15:289–297.CrossRefPubMed
5.
6.
go back to reference Cabrera-Perez J, Badovinac VP, Griffith TS. Enteric immunity, the gut microbiome, and sepsis: rethinking the germ theory of disease. Exp Biol Med (Maywood). 2017;242:127–139.CrossRefPubMed Cabrera-Perez J, Badovinac VP, Griffith TS. Enteric immunity, the gut microbiome, and sepsis: rethinking the germ theory of disease. Exp Biol Med (Maywood). 2017;242:127–139.CrossRefPubMed
7.
go back to reference Ates I, Dogan N, Aksoy M, Halıcı Z, Gündogdu C, Keles MS. The protective effects of IgM-enriched immunoglobulin and erythropoietin on the lung and small intestine tissues of rats with induced sepsis: biochemical and histopathological evaluation. Pharm Biol. 2015;53:78–84.CrossRefPubMed Ates I, Dogan N, Aksoy M, Halıcı Z, Gündogdu C, Keles MS. The protective effects of IgM-enriched immunoglobulin and erythropoietin on the lung and small intestine tissues of rats with induced sepsis: biochemical and histopathological evaluation. Pharm Biol. 2015;53:78–84.CrossRefPubMed
9.
go back to reference Santana PT, Benjamim CF, Martinez CG, Kurtenbach E, Takiya CM, Coutinho-Silva R. The P2X7 receptor contributes to the development of the exacerbated inflammatory response associated with sepsis. J Innate Immun. 2015;7:417–427.CrossRefPubMedPubMedCentral Santana PT, Benjamim CF, Martinez CG, Kurtenbach E, Takiya CM, Coutinho-Silva R. The P2X7 receptor contributes to the development of the exacerbated inflammatory response associated with sepsis. J Innate Immun. 2015;7:417–427.CrossRefPubMedPubMedCentral
10.
go back to reference Yang D, He Y, Muñoz-Planillo R, Liu Q, Núñez G. Caspase-11 requires the Pannexin-1 channel and the Purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity 2015;43:923–932.CrossRefPubMedPubMedCentral Yang D, He Y, Muñoz-Planillo R, Liu Q, Núñez G. Caspase-11 requires the Pannexin-1 channel and the Purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity 2015;43:923–932.CrossRefPubMedPubMedCentral
11.
go back to reference Guo R, Zhao G, Bai G et al. Depletion of mTOR ameliorates CD4+ T cell pyroptosis by promoting autophagy activity in septic mice. Int Immunopharmacol. 2023;124:110964.CrossRefPubMed Guo R, Zhao G, Bai G et al. Depletion of mTOR ameliorates CD4+ T cell pyroptosis by promoting autophagy activity in septic mice. Int Immunopharmacol. 2023;124:110964.CrossRefPubMed
12.
go back to reference Fagarasan S, Kawamoto S, Kanagawa O, Suzuki K. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol. 2010;28:243–273.CrossRefPubMed Fagarasan S, Kawamoto S, Kanagawa O, Suzuki K. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol. 2010;28:243–273.CrossRefPubMed
13.
go back to reference Zhang X-Y, Chen Xi, Zhang H-F et al. Propofol does not reduce pyroptosis of enterocytes and intestinal epithelial injury after lipopolysaccharide challenge. Dig Dis Sci. 2018;63:81–91.CrossRefPubMed Zhang X-Y, Chen Xi, Zhang H-F et al. Propofol does not reduce pyroptosis of enterocytes and intestinal epithelial injury after lipopolysaccharide challenge. Dig Dis Sci. 2018;63:81–91.CrossRefPubMed
14.
go back to reference Fuc E, Złotkowska D, Wasilewska E, Wróblewska B. OVA-experienced CD4+ T cell transfer and chicken protein challenge affect the immune response to OVA in a murine model. Int J Mol Sci. 2021;22:6573.CrossRefPubMedPubMedCentral Fuc E, Złotkowska D, Wasilewska E, Wróblewska B. OVA-experienced CD4+ T cell transfer and chicken protein challenge affect the immune response to OVA in a murine model. Int J Mol Sci. 2021;22:6573.CrossRefPubMedPubMedCentral
15.
go back to reference Chang Z, Zhang Y, Lin M et al. Improvement of gut-vascular barrier by terlipressin reduces bacterial translocation and remote organ injuries in gut-derived sepsis. Front Pharmacol. 2022;13:1019109.CrossRefPubMedPubMedCentral Chang Z, Zhang Y, Lin M et al. Improvement of gut-vascular barrier by terlipressin reduces bacterial translocation and remote organ injuries in gut-derived sepsis. Front Pharmacol. 2022;13:1019109.CrossRefPubMedPubMedCentral
16.
go back to reference Zhang X-Y, Liu Z-M, Zhang H-F et al. TGF-β1 improves mucosal IgA dysfunction and dysbiosis following intestinal ischaemia-reperfusion in mice. J Cell Mol Med. 2016;20:1014–1023.CrossRefPubMedPubMedCentral Zhang X-Y, Liu Z-M, Zhang H-F et al. TGF-β1 improves mucosal IgA dysfunction and dysbiosis following intestinal ischaemia-reperfusion in mice. J Cell Mol Med. 2016;20:1014–1023.CrossRefPubMedPubMedCentral
17.
go back to reference Zhang XY, Liu ZM, Wen SH et al. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats. Anesthesiology 2012;116:1035–1046.CrossRefPubMed Zhang XY, Liu ZM, Wen SH et al. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats. Anesthesiology 2012;116:1035–1046.CrossRefPubMed
18.
go back to reference Mouries J, Brescia P, Silvestri A et al. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J Hepatol. 2019;71:1216–1228.CrossRefPubMedPubMedCentral Mouries J, Brescia P, Silvestri A et al. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J Hepatol. 2019;71:1216–1228.CrossRefPubMedPubMedCentral
21.
go back to reference Osterberg J, Johnsson C, Gannedahl G, Westlund A, Haglund U. Alterations in mucosal immune cell distribution in septic rats. Shock 1997;7:182–185.CrossRefPubMed Osterberg J, Johnsson C, Gannedahl G, Westlund A, Haglund U. Alterations in mucosal immune cell distribution in septic rats. Shock 1997;7:182–185.CrossRefPubMed
22.
go back to reference Proietti M, Cornacchione V, Jost TR et al. ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer’s patches to promote host-microbiota mutualism. Immunity 2014;41:789–801.CrossRefPubMed Proietti M, Cornacchione V, Jost TR et al. ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer’s patches to promote host-microbiota mutualism. Immunity 2014;41:789–801.CrossRefPubMed
23.
go back to reference Liu Y, Zhang Y, Liu Q et al. Inhibition of DDX3X ameliorated CD4+ T cells pyroptosis and improves survival in septic mice. Mol Immunol. 2023;154:54–60.CrossRefPubMed Liu Y, Zhang Y, Liu Q et al. Inhibition of DDX3X ameliorated CD4+ T cells pyroptosis and improves survival in septic mice. Mol Immunol. 2023;154:54–60.CrossRefPubMed
24.
go back to reference Lai Y-N, Yeh S-L, Lin M-T, Shang H-F, Yeh C-L, Chen W-J. Glutamine supplementation enhances mucosal immunity in rats with Gut-Derived sepsis. Nutrition 2004;20:286–291.CrossRefPubMed Lai Y-N, Yeh S-L, Lin M-T, Shang H-F, Yeh C-L, Chen W-J. Glutamine supplementation enhances mucosal immunity in rats with Gut-Derived sepsis. Nutrition 2004;20:286–291.CrossRefPubMed
25.
go back to reference Fan J, Li G, Lidong Wu et al. Parenteral glutamine supplementation in combination with enteral nutrition improves intestinal immunity in septic rats. Nutrition 2015;31:766–774.CrossRefPubMed Fan J, Li G, Lidong Wu et al. Parenteral glutamine supplementation in combination with enteral nutrition improves intestinal immunity in septic rats. Nutrition 2015;31:766–774.CrossRefPubMed
26.
go back to reference Zeng Q, He X, Puthiyakunnon S et al. Probiotic mixture golden Bifido prevents neonatal Escherichia coli K1 translocation via enhancing intestinal defense. Front Microbiol. 2017;8:1798.CrossRefPubMedPubMedCentral Zeng Q, He X, Puthiyakunnon S et al. Probiotic mixture golden Bifido prevents neonatal Escherichia coli K1 translocation via enhancing intestinal defense. Front Microbiol. 2017;8:1798.CrossRefPubMedPubMedCentral
27.
go back to reference Dong X, Hao Tu, Bai X, Qin S, Li Z. Intrinsic/extrinsic apoptosis and pyroptosis contribute to the selective depletion of B cell subsets in septic shock patients. Shock 2023;60:345–353.CrossRefPubMedPubMedCentral Dong X, Hao Tu, Bai X, Qin S, Li Z. Intrinsic/extrinsic apoptosis and pyroptosis contribute to the selective depletion of B cell subsets in septic shock patients. Shock 2023;60:345–353.CrossRefPubMedPubMedCentral
28.
go back to reference Arulkumaran N, Sixma ML, Pollen S et al. P2X7 receptor antagonism ameliorates renal dysfunction in a rat model of sepsis. Physiol Rep. 2018;6:13622.CrossRef Arulkumaran N, Sixma ML, Pollen S et al. P2X7 receptor antagonism ameliorates renal dysfunction in a rat model of sepsis. Physiol Rep. 2018;6:13622.CrossRef
29.
go back to reference Zou Z, Wang Q, Zhou M et al. Protective effects of P2X7R antagonist in sepsis-induced acute lung injury in mice via regulation of circ_0001679 and circ_0001212 and downstream Pln, Cdh2, and Nprl3 expression. J Gene Med. 2020;22:e3261.CrossRefPubMed Zou Z, Wang Q, Zhou M et al. Protective effects of P2X7R antagonist in sepsis-induced acute lung injury in mice via regulation of circ_0001679 and circ_0001212 and downstream Pln, Cdh2, and Nprl3 expression. J Gene Med. 2020;22:e3261.CrossRefPubMed
30.
go back to reference Huang J, Wang Z, Zhang X et al. Lipidomics study of sepsis-induced liver and lung injury under anti-HMGB1 intervention. J Proteome Res. 2023;22:1881–1895.CrossRefPubMed Huang J, Wang Z, Zhang X et al. Lipidomics study of sepsis-induced liver and lung injury under anti-HMGB1 intervention. J Proteome Res. 2023;22:1881–1895.CrossRefPubMed
31.
go back to reference Xu-Yu Zhang Su, Guan H-F, Li R-Y, Liu Z-M. Activation of PD-1 protects intestinal immune defense through IL-10/miR-155 pathway after intestinal ischemia reperfusion. Dig Dis Sci. 2018;63:3307–3316.CrossRefPubMed Xu-Yu Zhang Su, Guan H-F, Li R-Y, Liu Z-M. Activation of PD-1 protects intestinal immune defense through IL-10/miR-155 pathway after intestinal ischemia reperfusion. Dig Dis Sci. 2018;63:3307–3316.CrossRefPubMed
Metadata
Title
Restoration of the Mucosal IgA Response by Improving CD4+ T Pyroptosis Fails to Attenuate Gut Bacterial Translocation and Organ Damage After LPS Attack
Authors
Zi-Meng Liu
Yi-nan Zhang
Hu-fei Zhang
Xiao-jun Chen
Hui Peng
Xu-Yu Zhang
Publication date
09-02-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08278-z

Other articles of this Issue 3/2024

Digestive Diseases and Sciences 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine